Watching Oracle shares as it looks to Cerner, cloud boost
Oracle’s results, due after the close, are set to give investors an update on how hybrid working is boosting its Cloud Infrastructure business.
And how much Cerner, the health information tech giant, is likely to contribute to future earnings.
(Video Transcript)
Oracle earnings
Oracle, an all-sessions stock on the IG platform, is set to hand in its fourth quarter (Q4) report card after the closing bell. Investors want to see how Oracle Cloud infrastructure has performed in recent months as the flexible work model is becoming more mainstream. In the third quarter (Q3), Oracle Cloud revenue accounted for 51% of its total revenue.
And in Q4, this is expected to rise to 53%. Another focus for investors, another center of interest, is Cerner the Health Information Tech Giant bought in 2022 for $28.3 billion, which contributed $1.5 billion of sales in the previous quarter. Now overall, the street anticipates earnings of $1 58 per share, a 2.6% rise on the same quarter a year ago. Sales are also forecast to rise 16% to $13.7 billion.
Share price chart
Just a look at Oracle's share price here, which has been moving steadily higher pretty much since October 2022. We've seen some form of resistance at the 9,000 level, and then again at 10,315, thereabouts, but it's broken above that, and it's now moving towards the next resistance point, which I have plotted for you at around 11,500 and beyond.
This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.
Seize your opportunity
Deal on the world’s stock indices today.
- Trade on rising or falling markets
- Get one-point spreads on the FTSE 100
- Unrivalled 24-hour pricing
See opportunity on an index?
Try a risk-free trade in your demo account, and see whether you’re on to something.
- Log in to your demo
- Try a risk-free trade
- See whether your hunch pays off
See opportunity on an index?
Don’t miss your chance – upgrade to a live account to take advantage.
- Get spreads from one point on the FTSE 100
- Trade more 24-hour indices than any other provider
- Analyse and deal seamlessly on smart, fast charts
See opportunity on an index?
Don’t miss your chance. Log in to take your position.
Live prices on most popular markets
- Equities
- Indices
- Forex
- Commodities
Prices above are subject to our website terms and agreements. Prices are indicative only. All share prices are delayed by at least 15 minutes.
Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.
